CureZone   Log On   Join
Image Embedded Re: o/t ~ big pharma funding cancer "research"
 
wombat Views: 2,847
Published: 12 years ago
 
This is a reply to # 1,718,887

Re: o/t ~ big pharma funding cancer "research"


http://www.aacr.org/home/about-us/aacr-foundation/corporateinstitutional-part...

 

American Association for Cancer Research

AACR Sustaining Membership - A Mutually Beneficial Partnership


Now more than ever before, successful commercial and non-profit organizations are pursuing opportunities to develop mutually beneficial partnerships and other collaborative relationships. Since 1993, AACR has been proud to serve the needs of its corporate supporters with the AACR Sustaining Membership Program.

The Sustaining Membership Program of the AACR offers an extraordinary opportunity to affiliate with AACR's prestigious scientific programs and with the record of scientific distinction and excellence achieved by the Association's 28,000 member researchers worldwide. Sustaining Membership in AACR demonstrates an organization's commitment to cancer research and provides invaluable visibility within the international biomedical research community.

Progress in cancer research depends on the rapid exchange of scientific information among laboratory and clinical researchers. Since 1907, AACR has fostered groundbreaking investigations in cancer throughout the world by providing scientists with the most important forums for the presentation of their research. Through its outstanding scientific meetings and scholarly journals, and a host of other programs, AACR continues to play a pivotal role in facilitating scientific advancement and accelerating progress against cancer.


Help Foster Cancer Research

Corporations and institutions choosing Sustaining Membership enjoy enhanced opportunities for interaction with AACR's individual scientists, as well as an array of practical membership benefits. More importantly, Sustaining Members become associated with the good name and high standards of AACR and its work to foster cancer research.

Current Major Sustaining Members:

abbott labs 
agilent technologies
amgen 
anticancer logo  
AstraZeneca 
bayer logo 
Bristol-Myers Squibb 
  eisai logo
                   Eli Lilly              emd
  Genentech
             GlaxoSmithKline
              
                  
         millennium
   novartis logo
  ortho logo
pfizer logo 
 sanofi
SuperGen 
  Theradex
                


                                                      
                                Benefits of Major Sustaining Membership


Current Sustaining Members:  

 Boehringer Ingelheim

Celgene

 

logo

 

 

Genzyme

osi pharma

Pezcoller Foundation
 

                 Servier

Taiho Pharmaceutical Co.

 

 
Printer-friendly version of this page Email this message to a friend
Alert Moderators
Report Spam or bad message  Alert Moderators on This GOOD Message

This Forum message belongs to a larger discussion thread. See the complete thread below. You can reply to this message!


 

Donate to CureZone


CureZone Newsletter is distributed in partnership with https://www.netatlantic.com


Contact Us - Advertise - Stats

Copyright 1999 - 2022  www.curezone.com

0.563 sec, (6)